Patient Education

Apr 02, 2025

Loneliness and biomarkers of brain pathology in people with subjective cognitive decline

Apr 01, 2025

Identifying progression subphenotypes of Alzheimer’s disease from large-scale electronic health records with machine learning

Apr 01, 2025

Associations of moderate alcohol intake with cerebrospinal fluid biomarkers of Alzheimer’s disease: data from the ALBION study

Mar 31, 2025

Age as a limiting factor for effectiveness of photostimulation of brain drainage and cognitive functions

Mar 31, 2025

N-Acetylcysteine for Hereditary Cystatin C Amyloid Angiopathy

Mar 26, 2025

Emerging biophysical origins and pathogenic implications of amyloid oligomers

Mar 24, 2025

Anti‐amyloid treatments: Why we think they are worth it

Mar 22, 2025

Protocol of the follow-up of patients with transthyretin amyloid cardiomyopathy by multimodality imaging (FAITH) study: a prospective observational study in patients with ATTR-CM undergoing treatment with tafamidis

Mar 21, 2025

Integrated specialty care for amyloidosis: a scoping review using the Consolidated Framework for Implementation Research

BackgroundAmyloidosis is a complex and rare disease requiring specialized, multidisciplinary care to effectively manage its diverse manifestations. Existing…

Mar 07, 2025

Demographic and clinical characteristics of initial patients receiving amyloid-targeting treatments in the United States after regulatory approval

AbstractIntroduction: Three treatments for Alzheimer's disease have been approved in the United States. Data are lacking on the characteristics of the initial…

1
2
3
4
5
6
7
8
9
…
Next page
Last page

Subscribe to